BIO-Asia Partnering Conference 2008 to Bring Together Biotechnology Leaders from North America, Europe and Asia

                WASHINGTON, D.C. (Wednesday, January 16, 2008) - Executives from biotechnology and pharmaceutical companies in North America, Europe and the Asia Pacific region will meet to explore business opportunities at the fifth annual BIO-Asia Partnering Conference.  Hosted by the Biotechnology Industry Organization (BIO), the customized partnering forum will take place January 28-29, 2008 at the Grand Hyatt Tokyo in Japan.

                Two well-known and respected industry leaders will present luncheon keynote speeches at the event.  Toshinari Tamura, Ph.D., representative director, executive vice president and chief science officer of Astellas Pharma Inc., will deliver the luncheon keynote on Monday, January 28, and James C. Mullen, president and chief executive officer of Biogen Idec, Inc. will deliver the luncheon keynote on Tuesday, January 29. 

                Thought provoking panel sessions add depth to the program, with sessions including:

                            ·         Trends in M&A and Partnering

                            ·         When Borders Break Down:  The New Generation of Asian Biotechnology Industry

                            ·         Examining the Different Regulatory Frameworks – Japan, US and Europe

                            ·         Asian Capital Formation Trends – How Not to Get Lost in Translation

                BIO-Asia is an exclusive partnering forum that brings together Asian-Pacific, North American and European biotechnology and pharmaceutical companies interested in research collaborations and licensing agreements.  The event features private, pre-arranged one-on-one meetings between senior-level executives and provides a number of ways to explore a range of exceptional international partnering and licensing opportunities.  Over the course of two days, BIO-Asia is expected to host more than 1,500 private meetings and provide countless formal and informal networking opportunities.  BIO-Asia 2007 attracted 500 professionals from more than 270 companies and 25 countries around the world.  With over 600 life science executives expected at BIO-Asia 2008, attendance is projected to break records for the fifth year in a row

                BIO-Asia is co-hosted by Mitsubishi UFJ Securities, Mitsubishi UFJ Capital, Montgomery & Co., and BioCentury Publications with support from Japan Bioindustry Association (JBA), Bioindustry Association of Korea (BAK), Association of Biotechnology Led Enterprises (ABLE), AusBiotech, and BIOTECanada.

                The BIO-Asia Partnering System is now open.  Register now to take maximum advantage of BIO’s unique, proprietary partnering technology before partnering schedules become full.  Meetings are scheduled with a priority given to attendees based on when they register

                For registration, a full list of participating companies and additional information, please visit  Media registration is complimentary to credentialed members of the media.  Please contact for media registration details.  If you have any questions, please contact

Upcoming BIO Events

 ·   BIO-Asia Partnering Conference 
    January 28-29, 2008
    Tokyo, Japan

 ·   BIO CEO & Investor Conference 
    February 11-13, 2008
    New York, NY

 ·   Partnering for Global Health  
    March 10-12, 2008
    Washington, DC

 ·   BIO-Europe Spring 
    April 7-9, 2008
    Madrid, Spain

 ·   BIO National Venture Conference 
    April 22-23, 2008
    Boston, Mass.

 ·   World Congress on Industrial Biotechnology & Bioprocessing  
    April 27-30, 2008
    Chicago, Ill.

 ·   2008 BIO International Convention 
    June 17-20, 2008
    San Diego, Calif.


About BIO

BIO represents more than 1,150 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. BIO also produces the annual BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.